ReCAP

 
 
  • Managing Obesity in Clinical Practice   Obesity medicine physicians discuss guidelines and best practices for managing overweight and obesity, including lifestyle changes, bariatric surgery, and therapies such as GLP-1 receptor agonists.
  • Obesity Management in Primary Care   Dr Chika V. Anekwe advises primary care physicians on how best to care for patients with obesity, including a framework for management and the emerging therapeutic options semaglutide and tirzepatide.
  • Pulmonary Risk Factors in Patients With Obesity   Treating obesity can positively affect pulmonary disease, but pulmonologists generally leave obesity management to other specialists. Two experts explore the benefits of an interdisciplinary approach.
  • Targeted Therapies for Triple-Negative Breast Cancer   Drs Tripathy and Yam discuss new therapeutic options that can benefit patients with triple-negative breast cancer, including PD-1 inhibitors, PARP inhibitors, and Trop-2 antibody-drug conjugates.
  • Improving Outcomes in Mantle Cell Lymphoma   Dr Ann LaCasce from the Dana-Farber Cancer Center reviews new and emerging therapies for patients with relapsed/refractory mantle cell lymphoma, including CAR T-cell therapy and bispecific antibodies.
  • Weight Management and the Well-Woman Exam   The well-woman medical exam is an opportunity to discuss weight management. Dr Carolyn Newberry clarifies the role of pharmacologic and surgical approaches when diet and exercise are not sufficient.
  • Managing Patients With Obesity and Impaired Renal Function   Dr Alex Chang discusses the importance of weight reduction in patients with obesity and impaired renal function as well as available therapies that address both conditions.
  • Biomarker Testing in Multiple Sclerosis   Research into new and emerging biomarkers in multiple sclerosis may help improve the assessment of disease activity, as reported by Dr Shiv Saidha from Johns Hopkins School of Medicine.
  • Early Identification and Treatment of SPMS   Progression of multiple sclerosis (MS) from relapsing-remitting MS to secondary progressive MS poses diagnostic and treatment challenges, as discussed by Dr Patricia K. Coyle.
  • Biosimilars and Oncology Pharmacy   Oncology pharmacy experts discuss the safety, efficacy, and cost-saving benefits of biosimilar use and emphasize the need for better education and formulary alignment to increase biosimilar adoption.
  • Current and Emerging Therapies in Refractory mCRC   Treatments for refractory metastatic colorectal cancer, from approved regorafenib and TAS-102 to promising new and emerging therapies including fruquintinib, are discussed by Dr John Marshall.
  • Evolving Approaches to COVID-19 Prevention   An infectious disease expert explains the importance of evolving vaccine designs to protect against the SARS-CoV-2 virus, which can rapidly mutate and replicate, increasing the spread of COVID-19.
  • Treating Focal Seizures in School-Age Children   The average US school has three to four students with epilepsy. Dr Anup Patel discusses treatment strategies for school-age children who have focal seizures (complex partial seizures.)
  • Managing Cardiovascular Risk in Patients With Chronic Kidney Disease   Dr Rajiv Agarwal discusses a proactive approach to cardiovascular risk management in patients with chronic kidney disease, including measuring albuminuria and prescribing cardioprotective therapies.
  • Treatment Options for Lowering LDL Cholesterol   Elevated LDL cholesterol can cause serious cardiovascular events. In this ReCAP, Dr Seth Martin discusses ways to lower LDL cholesterol in patients not responding to their current therapy.
  • Identifying and Treating Postpartum Depression   Postpartum depression is the most common complication of childbirth, yet it is frequently undertreated. In this ReCAP, Dr Jennifer Payne discusses the effects of PPD and available treatment options.
  • New Targets for Antibody-Drug Conjugates in NSCLC   Leading oncologists Drs Solange Peters and Jordi Remon discuss recent advances in antibody-drug conjugates (ADCs) in non–small cell lung cancer, including ADCs for emerging molecular targets.
  • Breast Cancer Survivorship in Veterans   Breast cancer experts discuss the challenges faced by veterans diagnosed with breast cancer and how the VA supports their long-term medical and psychosocial needs as cancer survivors.
  • Real-World Vaccination Outcomes for COVID-19   Dr Liem Binh Luong, of the Hôpital Cochin–Port Royal in Paris, reviews recent real-world data on vaccine effectiveness of the currently available COVID vaccines and differences in study methodologies.
  • Severe Asthma Management Including Biologic Therapy   Multidisciplinary assessment of severe asthma may be necessary to achieve optimal management with conventional therapies or one of the broad range of available biologics.